This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Breast cancer patients aged ≥ 18 years with an ECOG score > 1
Breast cancer patients with post-axillary lymph node dissection diagnosed with stage 0 and I lymphedema.
Those who have never undergone lymphedema physiotherapy.
Patients with dermal backflow before axillary lymph node dissection (ALND).
Patients with breast cancer lymphedema who are unable to undergo a 24-month follow-up at Dharmais Cancer Hospital.
Patients with iodine allergy, severe asthma, decreased kidney function, pregnancy, or breastfeeding.